Matinas BioPharma Holdings, Inc. (MTNB) stock
MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.91+0.05 (+6.35%)
Close on Nov 18, 2026Market cap $13.37MP/E –Yield –
Matinas BioPharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Matinas BioPharma's revenue for the twelve months ending Dec 31, 2023 was $1.10M, down 65.6% year over year. For fiscal 2023 it was $1.10M, down 65.6% from the year before. The highest annual figure on record is $3.19M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.10M | -65.6% |
| FY2022 | Dec 31, 2022 | $3.19M | +9560.6% |
| FY2021 | Dec 31, 2021 | $33.00K | -79.2% |
| FY2020 | Dec 31, 2020 | $158.33K | +76.3% |
| FY2019 | Dec 31, 2019 | $89.81K | -25.0% |
| FY2018 | Dec 31, 2018 | $119.75K | -20.0% |
| FY2017 | Dec 31, 2017 | $149.69K | – |
| FY2016 | Dec 31, 2016 | $0 | -100.0% |
| FY2015 | Dec 31, 2015 | $194.49K | – |
| FY2014 | Dec 31, 2014 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.10M | – |
| Q4 FY2022 | Dec 31, 2022 | $1.06M | – |
| Q3 FY2022 | Sep 30, 2022 | $1.06M | – |
| Q2 FY2022 | Jun 30, 2022 | $1.06M | +3089.0% |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q1 FY2021 | Mar 31, 2021 | $33.33K | – |
| Q4 FY2020 | Dec 31, 2020 | $62.50K | -30.4% |
| Q3 FY2020 | Sep 30, 2020 | $95.83K | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | -100.0% |
| Q2 FY2019 | Jun 30, 2019 | $89.81K | +200.0% |
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $0 | -100.0% |
| Q2 FY2018 | Jun 30, 2018 | $89.81K | +100.0% |
| Q1 FY2018 | Mar 31, 2018 | $29.94K | +100.0% |
| Q4 FY2017 | Dec 31, 2017 | $44.91K | – |
| Q3 FY2017 | Sep 30, 2017 | $44.91K | – |
| Q2 FY2017 | Jun 30, 2017 | $44.91K | – |
| Q1 FY2017 | Mar 31, 2017 | $14.97K | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?